In a recent study posted to the medRxiv* preprint server, researchers investigate the effect of colonization of the upper respiratory tract (URT) by Streptococcus pneumoniae on severe acute ...
To understand how this pathogen adapts to different locations in the body, and also how the host responds to the invading microbe, researchers at the University of Alabama at Birmingham, the ...
In a recent study posted to the medRxiv* preprint server, researchers from Germany conducted a population-based surveillance study to ascertain the etiology of community-acquired pneumonia (CAP) ...
BOSTON--(BUSINESS WIRE)--Vaccine development company Matrivax announces the start of its Phase 1 clinical study to assess the safety, tolerability, and immunogenicity of its lead pneumococcal disease ...
CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Affinivax, Inc. ("Affinivax") and Astellas Pharma Inc. (“Astellas”) announced results from the Phase 2 clinical trial of ASP3772, a novel vaccine candidate ...
Researchers have found a further reason for the severity of dual infection by influenza and Streptococcus pneumonia -- a new virulence mechanism for a surface protein on the pneumonia-causing bacteria ...
Readers are encouraged to respond to George Lundberg, MD, Editor of MedGenMed, for the editor's eye only or for possible publication via email: [email protected] Disclosure: Stephen Brunton, MD, ...
Community-acquired pneumonia (CAP) remains a major cause of illness and death worldwide, particularly among the elderly and individuals with underlying conditions. Streptococcus pneumoniae is the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback